Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 81-90 of 550 total displayed.

Past content

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes

Raffaele Marfella; Michelangela Barbieri; Giuseppe Paolisso
JAMA 2008; 300: 789. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes—Reply

Roger H. Unger
JAMA 2008; 300: 790. [Extract] [Full text] [PDF]  

Letters
Fatty Acid and Vitamin D Status in the EPIC Trials of Crohn Disease Treatment—Reply

Brian G. Feagan
JAMA 2008; 300: 650-a. [Extract] [Full text] [PDF]  

Letters
Fatty Acid and Vitamin D Status in the EPIC Trials of Crohn Disease Treatment

Gregory A. Plotnikoff
JAMA 2008; 300: 650. [Extract] [Full text] [PDF]  

Editorials
Body Fat Distribution and Cardiovascular Risk: A Tale of 2 Sites

Lewis Landsberg
Arch Intern Med 2008; 168: 1607-1608. [Extract] [Full text] [PDF]  

Original Investigations
Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy

Ronald B. Goldberg; Vivian A. Fonseca; Kenneth E. Truitt; Michael R. Jones
Arch Intern Med 2008; 168: 1531-1540. [Abstract] [Full text] [PDF]  

Letters
Oral Hypoglycemic Use and the SANDS Trial—Reply

Barbara V. Howard; William James Howard; Robert E. Ratner
JAMA 2008; 300: 389-a-390-a. [Extract] [Full text] [PDF]  

Letters
Oral Hypoglycemic Use and the SANDS Trial

Eva L. Evans; Rohit P. Ojha; Lori A. Fischbach
JAMA 2008; 300: 389. [Extract] [Full text] [PDF]  

Letters
Anandamide as a Marker of Human Disease

Mauro Maccarrone
JAMA 2008; 300: 281-282. [Extract] [Full text] [PDF]  

Letters
Anandamide as a Marker of Human Disease—Reply

Osama M. H. Habayeb; Anthony H. Taylor; Justin C. Konje
JAMA 2008; 300: 282. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55